drugset / Trial / NCT01742078
A Study of LY2541546 in Healthy Postmenopausal Women
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to determine if a single dose of LY2541546 has any side effects on the body and to determine how long and how much LY2541546 stays in the bloodstream of the body.
Timeline
- Start
- 2008-06
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Blosozumab | Monoclonal antibody | 7.5 mg | Intravenous |
| Subject | Blosozumab | Monoclonal antibody | 25 mg | Intravenous |
| Subject | Blosozumab | Monoclonal antibody | 75 mg | Intravenous |
| Subject | Blosozumab | Monoclonal antibody | 150 mg | Intravenous |
| Subject | Blosozumab | Monoclonal antibody | 225 mg | Intravenous |
| Subject | Blosozumab | Monoclonal antibody | 750 mg | Intravenous |
Indications
No indication recorded.